The challenges of translation
Abstract Cancer immunotherapy is a highly active area in translational medicine where the challenges and rewards of developing new drugs “from bench to bedside” become particularly visible. Here, we comment on both, the scientific and non‐scientific hurdles of this translational process using the ex...
Saved in:
| Main Authors: | Helmut R Salih, Gundram Jung |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Springer Nature
2019-10-01
|
| Series: | EMBO Molecular Medicine |
| Online Access: | https://doi.org/10.15252/emmm.201910874 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Platelets subvert antitumor efficacy of T cell-recruiting bispecific antibodies
by: Melanie Märklin, et al.
Published: (2022-02-01) -
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies
by: Hans-Georg Rammensee, et al.
Published: (2020-05-01) -
CLEC12A-directed immunocytokine with target cell–restricted IL-15 activity for treatment of acute myeloid leukemia
by: Boris Klimovich, et al.
Published: (2025-03-01) -
INTERTEXTUALITY AND THE CHALLENGES OF TRANSLATION
by: Elena KREJCOVA
Published: (2025-03-01) -
Translational Challenges in Cancer Nanotherapy
by: Ammu V. V. V. Ravi Kiran, et al.
Published: (2024-07-01)